Azenta Inc - Company Profile
Powered by 
All the sales intelligence you need on Azenta Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Azenta Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Azenta Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Azenta Inc (Azenta), formerly Brooks Automation Inc, provides sample exploration and management solutions for the life sciences industry. The company’s product portfolio includes automated storage systems, vaccine cold storage and transport, genomic services, and sample management solutions. It also offers services supporting customers at every stage of the life cycle of samples, including procurement and a multitude of sample consumables, informatics and data software, along with sample repository services. Azenta's offerings find application in pharmaceutical, biotechnology, and life sciences research institutions. The company operates through manufacturing facilities in Missouri, the US; Manchester, the UK; and Hosingen, Luxembourg. Azenta is headquartered in Burlington, Massachusetts, the US.
Headquarters
United States of America
Address
200 Summit Drive, 6th Floor, Burlington, Massachusetts, 01803
Website
www.azenta.com
Telephone
1 888 2293682
No of Employees
3,000
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
AZTA (NASD)
Revenue (2024)
$593.8M
3.6%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
66.2%
(2024 vs 2023)
Market Cap*
$1.3B
Net Profit Margin (2024)
XYZ
67.4%
(2024 vs 2023)
* As of and is in US$
Azenta Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Consumables and Instruments: | GENEWIZ Multiomics and Synthesis Solutions: | GENEWIZ |
| Sample Tubes | Next Generation Sequencing | BMedical |
| PCR/Microplates | Proteomics | Barkey |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Acquisitions/Mergers/Takeovers | In March, Azenta UK acquired UK Biocentre Limited, a provider of sample management, sample storage and high-throughput sample processing services. |
| 2026 | Contracts/Agreements | In February, the company partnered with Frontier Space to conduct scientific experiments in microgravity aboard the EGGS-2 mission to validate its sample management technologies for space research. |
| 2025 | Contracts/Agreements | In December, Azenta Germany GmbH entered into an agreement to sell its B Medical Systems business to THELEMA S.A R.L. for US$63 million. |
Competitor Comparison
| Key Parameters | Azenta Inc | Thermo Fisher Scientific Inc | Labcorp Holdings Inc | Eurofins Scientific SE | GenScript Biotech Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | Luxembourg | China |
| City | Burlington | Waltham | Burlington | Luxembourg | Nanjing |
| State/Province | Massachusetts | Massachusetts | North Carolina | - | Jiangsu |
| No. of Employees | 3,000 | 125,000 | 71,000 | 65,694 | 6,165 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Frank E. Casal | Chairman | Executive Board | 2021 | - |
| John Marotta | President; Chief Executive Officer; Director | Executive Board | 2024 | - |
| Lawrence Lin | Executive Vice President; Chief Financial Officer | Senior Management | 2024 | - |
| Michael Paulo | Chief Information and Digital Officer; Vice President | Senior Management | 2017 | - |
| Olga Pirogova | Chief Human Resources Officer; Senior Vice President | Senior Management | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer